{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04104776",
            "orgStudyIdInfo": {
                "id": "CPI-0209-01"
            },
            "organization": {
                "fullName": "Constellation Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas",
            "officialTitle": "A Phase 1/2 Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-of-cpi-in-patients-with-advanced-solid-tumors-and-lymphomas"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-09-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-03-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-09-23",
            "studyFirstSubmitQcDate": "2019-09-24",
            "studyFirstPostDateStruct": {
                "date": "2019-09-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Constellation Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209 is a small molecule inhibitor of EZH2.",
            "detailedDescription": "Emerging evidence suggests that EZH2 is overexpressed in many cancer types and has a pivotal role in disease progression. This is a Phase 1/2, open-label, multi-center, FIH study designed to evaluate the safety and tolerability and preliminary clinical activity of CPI-0209, an EZH2/1 inhibitor as monotherapy in patients with advanced solid tumors and lymphomas. Phase 1 is composed of a CPI-0209 Dose Escalation period in patients with advanced tumors and aims to determine maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of CPI-0209 as monotherapy in patients with advanced tumors.\n\nPhase 2 is planned to evaluate safety and tolerability and antitumor activity of CPI-0209 in six disease-specific cohorts (M1 to M6). Patients in Cohorts M1, M2, M3, M5, and M6 will be enrolled at 10 to 29 patients per cohort, using a Simon 2-stage design. Cohort M4 will enroll up to 20 patients with lymphoma in a single-stage. The primary aim of Phase 2 part of the study is to evaluate the antitumor activity of CPI-0209, and characterize the safety and tolerability of CPI-0209 as monotherapy in patients with selected tumors.\n\nIn Phase 2, two additional doses are planned to be evaluated in cohorts M2 and M3 in 2 stages: Stage 2a and Stage 2b. In Stage 2a approximately 20 patients will be enrolled per cohort and will be randomized 1:1 to receive 2 prespecified dose levels of CPI-0209 once daily. When protocol criteria for initiating Stage 2b will be fulfilled after completion of Stage 2a, then Stage 2b will be opened for enrolment of additional 10 patients in one or both dose arms in each of the two cohorts. Thus, up to 40 patients per cohort (M2 and M3) could be enrolled."
        },
        "conditionsModule": {
            "conditions": [
                "Advanced Solid Tumor",
                "Diffuse Large B Cell Lymphoma",
                "Lymphoma, T-Cell",
                "Mesothelioma, Malignant",
                "Prostatic Neoplasms, Castration-Resistant",
                "Endometrial Cancer",
                "Ovarian Clear Cell Carcinoma"
            ],
            "keywords": [
                "Lymphoma, Large B-Cell, Diffuse",
                "Lymphoma, B-cell",
                "Lymphoma, T-cell",
                "Lymphoma, Non-Hodgkin",
                "Lymphoma",
                "Neoplasms by Site",
                "Neoplasms by Histologic Type",
                "Neoplasms",
                "Lymphoproliferative Disorders",
                "Lymphatic Diseases",
                "Immunoproliferative Disorders",
                "Immune System Diseases",
                "Topoisomerase Inhibitors",
                "Molecular Mechanisms of Pharmacological Action",
                "Antineoplastic Agents",
                "Endometrial Cancer",
                "Ovarian Clear Cell Carcinoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 210,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phase 2 Cohort M1",
                    "type": "EXPERIMENTAL",
                    "description": "CPI-0209 will be dosed once per day orally in 28 day cycles.\n\n\u2022 Cohort M1: patients with urothelial carcinoma or other advanced/metastatic solid tumors (with known ARID1A mutation)",
                    "interventionNames": [
                        "Drug: CPI-0209"
                    ]
                },
                {
                    "label": "Phase 2 Cohort M2",
                    "type": "EXPERIMENTAL",
                    "description": "CPI-0209 will be dosed once per day orally in 28 day cycles.\n\n\u2022 Cohort M2 patients with ovarian clear cell carcinoma (with known ARID1A mutation)",
                    "interventionNames": [
                        "Drug: CPI-0209"
                    ]
                },
                {
                    "label": "Phase 2 Cohort M3",
                    "type": "EXPERIMENTAL",
                    "description": "CPI-0209 will be dosed once per day orally in 28 day cycles.\n\n\u2022 Cohort M3 patients with endometrial carcinoma (with known ARID1A mutation)",
                    "interventionNames": [
                        "Drug: CPI-0209"
                    ]
                },
                {
                    "label": "Phase 2 Cohort M4",
                    "type": "EXPERIMENTAL",
                    "description": "CPI-0209 will be dosed once per day orally in 28 day cycles.\n\n\u2022 Cohort M4 patients with peripheral T-cell lymphoma (PTCL) and patients with diffuse large B-cell lymphoma (DLBCL), including patients with documented germinal center B cell like diffuse large B-cell lymphoma (GCB-DLBCL) with at least 1 EZH2 hotspot mutation",
                    "interventionNames": [
                        "Drug: CPI-0209"
                    ]
                },
                {
                    "label": "Phase 2 Cohort M5",
                    "type": "EXPERIMENTAL",
                    "description": "CPI-0209 will be dosed once per day orally in 28 day cycles.\n\n\u2022 Cohort M5 patients with relapsed or refractory malignant pleural or peritoneal mesothelioma with known BAP1 loss",
                    "interventionNames": [
                        "Drug: CPI-0209"
                    ]
                },
                {
                    "label": "Phase 2 Cohort M6",
                    "type": "EXPERIMENTAL",
                    "description": "CPI-0209 will be dosed once per day orally in 28 day cycles.\n\n\u2022 Cohort M6 patients with castration-resistant prostate cancer(mCRPC) with measurable soft tissue disease",
                    "interventionNames": [
                        "Drug: CPI-0209"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "CPI-0209",
                    "description": "CPI-0209 alone",
                    "armGroupLabels": [
                        "Phase 2 Cohort M1",
                        "Phase 2 Cohort M2",
                        "Phase 2 Cohort M3",
                        "Phase 2 Cohort M4",
                        "Phase 2 Cohort M5",
                        "Phase 2 Cohort M6"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Phase 1: Frequency of Dose-limiting toxicities (DLTs)",
                    "description": "The maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D) of CPI-0209 in patients with advanced tumors",
                    "timeFrame": "DLTs assessed during Cycle 1 (first 28 days on study)"
                },
                {
                    "measure": "Phase 2: Overall response rate (ORR)",
                    "description": "ORR is defined as the proportion of patients with a best overall response of complete response (CR) or partial response (PR) based on RECIST 1.1 or applicable response criteria",
                    "timeFrame": "18 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Phase 1 Adverse events (AEs) and change in laboratory values",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: PK parameters",
                    "description": "Cmax",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: PK parameters",
                    "description": "Tmax",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: PK parameters",
                    "description": "AUC0-last",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: PK parameters",
                    "description": "AUC0-Inf",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: PK parameters",
                    "description": "t1/2",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: PK parameters",
                    "description": "Cmin",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: PD parameters",
                    "description": "Gene expression in blood cells",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: PD parameters",
                    "description": "H3K27me3",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: ORR",
                    "description": "ORR, defined as proportion of patients with a best overall response of CR or PR) based on RECIST 1.1 or applicable response criteria",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: ORR per Gynecologic Cancer",
                    "description": "ORR per Gynecologic Cancer Intergroup (GCIG)-defined CA-125 response criteria (ovarian cancer patients)",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: ORR per prostate cancer",
                    "description": "ORR per Prostate Cancer Clinical Trials Working Group 3 (PCWG3)",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: Progression-free survival (PFS)",
                    "description": "PFS, defined as the time from first dose to confirmed disease progression or death",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: Duration of response (DOR)",
                    "description": "DOR, defined as the time from the date of first response to the date of confirmed disease progression",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: Time to response (TTR)",
                    "description": "Time to response, defined as the time from first dose to date of first response",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 1: Disease control rate",
                    "description": "\\[Disease control rate, defined as the proportion of patients with a best overall response of CR, PR, or stable disease",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Phase 2: PFS",
                    "description": "PFS, defined as the time from first dose to confirmed disease progression or death",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: Time-to-progression",
                    "description": "Time-to-progression (TTP)",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: DOR",
                    "description": "DOR, defined as the time from the date of first response to the date of confirmed disease progression",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: TTR",
                    "description": "TTR, defined as the time from first dose to date of first response",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: Disease control rate",
                    "description": "Disease control rate, defined as the proportion of patients with a best overall response of CR, PR or SD per cohort and CPI-0209 dose level",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: ORR",
                    "description": "ORR per GCIG-defined CA-125 response criteria (ovarian cancer patients)",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: Overall survival (OS)",
                    "description": "OS, defined as the time from first dose to death",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: Incidences of AEs",
                    "description": "Number of Participants With Adverse Events (AEs)",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: PK parameters",
                    "description": "Cmax",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: PK parameters",
                    "description": "Tmax",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: PK parameters",
                    "description": "AUC0-last",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: PK parameters",
                    "description": "AUC0-inf",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: PK parameters",
                    "description": "T1/2",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: PK parameters",
                    "description": "Cmin",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: PD parameters",
                    "description": "Gene expression in blood cells",
                    "timeFrame": "30 months"
                },
                {
                    "measure": "Phase 2: PD parameters",
                    "description": "H3K27me3 levels",
                    "timeFrame": "30 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nPhase 1\n\nEligible Phase 1 patients are adults who have a confirmed locally advanced or metastatic tumors (solid tumors or lymphoma) that have relapsed following standard therapy or progressed through standard therapy or who have a disease for which no standard effective therapy exists.\n\nPhase 2:\n\n* Life expectancy of \u2265 12 weeks\n* ECOG 0-1\n* Adequate bone marrow function\n* Adequate renal function\n* Adequate liver function\n\nFor Cohort M1, the following criteria should be considered:\n\n* Histologically confirmed locally advanced unresectable or metastatic urothelial carcinoma with predominant urothelial histology\n* \u2022 Histologically confirmed metastatic solid tumor (except ovarian clear cell cancer, endometrial cancer, and pleural or peritoneal mesothelioma)\n* Known ARID1A mutation (NGS testing)\n* Disease progression during or following prior chemotherapy approved therapies or for which no standard therapy exists\n* Measurable disease per RECIST 1.1\n\nFor Cohort M2, the following criteria should be considered:\n\n* Histologically confirmed advanced ovarian clear cell carcinoma\n* Known ARID1A mutation (by NGS testing)\n* Received at least 1 line of platinum-based chemotherapy and must have received bevacizumab as part of any line of treatments unless contraindicated or locally not approved or locally not accessible\n* Measurable disease per RECIST 1.1\n* Patient must have disease progression after previously receiving effective and available standard of care treatment for clear cell ovarian cancer per local clinical practice\n\nFor Cohort M3, the following criteria should be considered:\n\n* Histologically or cytologically confirmed recurrent, metastatic, or unresectable endometrial carcinoma\n* Known ARID1A mutation (by NGS testing)\n* Received at least 1 line of platinum-based regimen in recurrent/metastatic setting\n* Documented microsatellite instability (MSI)-high or deficient mismatch repair (dMMR) or patients who have non-dMMR/microsatellite stable tumors should have received an anti-PD-1 or anti-PD-L1 agent alone or in combination with the approved agents as applicable, as part of their prior treatments unless considered not eligible, contraindicated or if not locally approved\n* Brachytherapy is allowed if completed \\>12 weeks before the first dose of study drug\n* Measurable disease per RECIST 1.1\n* Patients must have previously received effective and available standard of care treatment options for endometrial cancer per local clinical practice unless these are contraindicated\n\nFor Cohort M4, the following criteria should be considered:\n\n* PTCL or DLBCL with the following criteria:\n* PTCL\n* Documented refractory, relapsed, or progressive disease after at least 1 prior line of systemic therapy. Refractory is defined as:\n* Failure to achieve CR after first-line therapy\n* Failure to reach at least PR after second-line therapy or beyond\n* Must have at least 1 prior line of systemic therapy for PTCL.\n* Participants must be considered hematopoietic cell transplantation (HCT) ineligible during screening due to disease status (active disease), comorbidities, or other factors; the reason for HCT ineligibility must be clearly documented.\n* In the PTCL cohort, participants with anaplastic large cell lymphoma (ALCL) must have prior brentuximab vedotin treatment.\n* DLBCL:\n* Relapsed or refractory disease following 2 or more prior lines of standard therapy.\n* Not considered candidates to receive CAR-T or autologous hematopoietic stem cell transplant (ASCT) as assessed by the treating investigator for reasons such as age, underlying comorbidities, performance status, or due to disease progression after previously received ASCT or CAR-T. The reason for transplant ineligibility must be clearly documented.\n* For patients who underwent past ASCT or CAR-T treatment, at least 90 days must have elapsed since the start of the procedure. For all other patients, at least 8 weeks must have elapsed since their most recent systemic anti-DLBCL therapy\n\nFor Cohort M5, the following criteria should be considered:\n\n* Pleural or peritoneal relapsed/refractory mesothelioma\n* Must have progressed on or after at least 1 prior line of active therapy\n* Measurable disease per modified RECIST 1.1 for pleural mesothelioma or by RECIST 1.1 for peritoneal mesothelioma\n* Known BAP1 loss per immunohistochemistry (IHC) or NGS\n\nFor Cohort M6, the following criteria should be considered:\n\n* Have measurable soft-tissue disease\n* Documented metastatic disease\n* Disease progression while on prior therapies\n* Baseline testosterone \u226450 ng/dL (\u22642.0 nM) and surgical or ongoing medical castration must be maintained throughout the duration of the study\n\nExclusion Criteria\n\nMedical Conditions\n\n* Previous solid organ or allogeneic hematopoietic cell transplant (HCT)\n* Known symptomatic untreated brain metastases\n* Clinically significant cardiovascular disease\n* Major surgery within 4 weeks before starting study drug or not recovered from any effects of prior major surgery\n* Gastrointestinal disorders or any other condition that may significantly interfere with absorption of the study medication by Investigator's assessment.\n* Uncontrolled active infection requiring intravenous antibiotic, antiviral, or antifungal medications within 14 days before the first dose of study drug. Infections (eg, urinary tract infection) controlled on concurrent antimicrobial agents and antimicrobial prophylaxis per institutional guidelines are acceptable.\n* Suspected pneumonitis or interstitial lung disease or a history of pneumonitis or interstitial lung disease.\n* Have a history of a concurrent or second malignancy. Patients with a history of T-cell lymphoblastic lymphoma or T-Cell lymphoblastic leukemia are not eligible.\n* Have current known active or chronic infection with HIV, hepatitis B, or hepatitis C. Screening of patients with serologic testing for these viruses is not required\n* Clinically active or symptomatic viral hepatitis or chronic liver disease.\n* Unstable or severe uncontrolled medical condition or any important medical or psychiatric illness or abnormal laboratory finding\n* Previous solid organ or allogeneic hematopoietic cell transplant HCT.\n\nPrior/Concomitant Therapy:\n\n* Prior anticancer treatment:\n\n  * Prior systemic anticancer treatment with chemotherapy, targeted therapy, small molecule, antibody, or investigational anticancer therapy (includes prior PD-1 or PD-L1 therapy), or other anticancer therapeutic with the exception of gonadotropin releasing hormone analogues, within 4 weeks (or 5 half-lives), whichever is shorter, before the first dose of study drug (6 weeks washout for nitrosoureas or mitomycin C).\n  * Previous treatment with an EZH2 inhibitor\n  * Prior radiation therapy within 4 weeks before first dose of study drug\n  * Prior stereotactic body radiation therapy within 2 weeks before first dose of study drug\n  * Prior chemoembolization or radioembolization within 4 weeks before first dose of study drug.\n* Concomitant medication(s) or food or beverage that are strong CYP3A inducers or inhibitors within 7 days prior to the first dose of study drug.\n\nOther Exclusions\n\n\u2022 Breastfeeding or pregnant woman or expecting to conceive or father children within the projected duration of the trial, starting with the Screening visit through 183 days after the last dose of study drug.\n\nCohort M6 (mCRPC) only\n\n* Bone-only disease without nodal disease and no evidence of visceral spread\n* Structurally unstable bone lesions concerning for impending fracture\n* Herbal products that may decrease prostate-specific antigen within 4 weeks prior to Day 1 of treatment and while on study\n* Treatment for prostate cancer (First generation androgen receptor antagonists within 4 weeks; 5\u03b1-reductase inhibitors, ketoconazole, estrogens, or progesterones within 2 weeks)\n* Planned palliative procedures such as radiation therapy or surgery",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Medical Information",
                    "role": "CONTACT",
                    "phone": "(844) 667-1992",
                    "email": "medinfo@morphosys.com"
                }
            ],
            "locations": [
                {
                    "facility": "Winship Cancer Institute of Emory University",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Adam Burgess",
                            "role": "CONTACT",
                            "phone": "404-712-9858",
                            "email": "adam.burgess@emory.edu"
                        },
                        {
                            "name": "R. Donald Harvey, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "University of Chicago Medical Center",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Iryna Kobrynets",
                            "role": "CONTACT",
                            "phone": "773-834-6421",
                            "email": "Iryna.Kobrynets@bsd.uchicago.edu"
                        },
                        {
                            "name": "Hedy Kindler, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "University of Maryland - Marlene and Stewart Greenebaum Cancer Center",
                    "status": "COMPLETED",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21201",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Terry Liu",
                            "role": "CONTACT",
                            "phone": "617-632-9250",
                            "email": "TLIU32@mgh.harvard.edu"
                        },
                        {
                            "name": "Ryan Sullivan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Dana Farber Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brian Rasp",
                            "role": "CONTACT",
                            "phone": "857-215-2265",
                            "email": "Brian_Rasp@DFCI.Harvard.edu"
                        },
                        {
                            "name": "Alok Tewari, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Michigan Hospital",
                    "status": "COMPLETED",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "South Texas Accelerated Research Therapeutics (Start) - Midwest Location",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49546",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yvette S Cole, MPH",
                            "role": "CONTACT",
                            "phone": "616-954-5554",
                            "email": "Yvette.Cole@startmidwest.com"
                        },
                        {
                            "name": "Yvette Cole, RN",
                            "role": "CONTACT",
                            "phone": "616-389-1652",
                            "email": "yvette.cole@startmidwest.com"
                        },
                        {
                            "name": "Nehal Lakhani, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "Hackensack University Medical Center",
                    "status": "RECRUITING",
                    "city": "Hackensack",
                    "state": "New Jersey",
                    "zip": "07601",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Celina Joco",
                            "role": "CONTACT",
                            "phone": "551-996-8170",
                            "email": "Celina.Joco@hmhn.org"
                        },
                        {
                            "name": "Martin Gutierrez, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.88593,
                        "lon": -74.04347
                    }
                },
                {
                    "facility": "Montefiore Einstein Center for Cancer Care",
                    "status": "COMPLETED",
                    "city": "Bronx",
                    "state": "New York",
                    "zip": "10461",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.84985,
                        "lon": -73.86641
                    }
                },
                {
                    "facility": "NYU Langone Medical Center - Laura and Isaac Perlmutter Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Stephen Cumberbatch",
                            "role": "CONTACT",
                            "phone": "407-517-8471",
                            "email": "Stephen.Cumberbatch@nyulangone.org"
                        },
                        {
                            "name": "Salman Punekar, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Weill Medical College of Cornell University",
                    "status": "COMPLETED",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "University of Cincinnati Medical Center",
                    "status": "COMPLETED",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45219",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "South Texas Accelerated Research Therapeutics",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Janet Garza, RN",
                            "role": "CONTACT",
                            "phone": "210-593-5252",
                            "email": "Janet.Garza@startsa.com"
                        },
                        {
                            "name": "Carrie Choi, RN",
                            "role": "CONTACT",
                            "phone": "210-593-2547",
                            "email": "carrie.choi@startsa.com"
                        },
                        {
                            "name": "Drew Rasco, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "University of Virginia Health System",
                    "status": "RECRUITING",
                    "city": "Charlottesville",
                    "state": "Virginia",
                    "zip": "22903",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Chrystal Axford",
                            "role": "CONTACT",
                            "phone": "804-683-2880",
                            "email": "Cgp9e@hscmail.mcc.virginia.edu"
                        },
                        {
                            "name": "Linda Duska, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.02931,
                        "lon": -78.47668
                    }
                },
                {
                    "facility": "Swedish Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Chun-Fang Qiu",
                            "role": "CONTACT",
                            "phone": "206-215-6430",
                            "email": "Chun-fang.Qiu@swedish.org"
                        },
                        {
                            "name": "Charles Drescher, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "Fred Hutchinson Cancer",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109-1023",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elizabeth Liu",
                            "role": "CONTACT",
                            "phone": "206-606-7494",
                            "email": "elizliu@seattlecca.org"
                        },
                        {
                            "name": "Kalyan Banda, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "Bergonie Institute",
                    "status": "RECRUITING",
                    "city": "Bordeaux",
                    "zip": "33000",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Laura Wanner",
                            "role": "CONTACT",
                            "phone": "+33 (556) 333-282",
                            "email": "l.wanner@bordeaux.unicancer.fr"
                        },
                        {
                            "name": "Antoine Italiano",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.84044,
                        "lon": -0.5805
                    }
                },
                {
                    "facility": "Oscar Lambret Center",
                    "status": "RECRUITING",
                    "city": "Lille",
                    "zip": "59020",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Solaya Chalal",
                            "role": "CONTACT",
                            "phone": "+33 (0) 3 20 29 56 38",
                            "email": "s-chalal@o-lambret.fr"
                        },
                        {
                            "name": "Cyril Abdeddaim",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.63297,
                        "lon": 3.05858
                    }
                },
                {
                    "facility": "Leon Berard Center",
                    "status": "RECRUITING",
                    "city": "Lyon",
                    "zip": "69373",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Emilie Repetto",
                            "role": "CONTACT",
                            "phone": "+33 (0) 4 78 78 20 62",
                            "email": "emilie.repetto@lyon.unicancer.fr"
                        },
                        {
                            "name": "Mehdi Brahmi",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.74848,
                        "lon": 4.84669
                    }
                },
                {
                    "facility": "Hospital North",
                    "status": "RECRUITING",
                    "city": "Nantes",
                    "zip": "44093",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Helene Godet",
                            "role": "CONTACT",
                            "phone": "+33 (0) 2 40 16 56 98",
                            "email": "helene.godet@chu-nantes.fr"
                        },
                        {
                            "name": "Thomas Gastinne, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "Nantes University Hospital Center - Hotel Dieu Hospital (Satellite)",
                    "status": "RECRUITING",
                    "city": "Nantes",
                    "zip": "44093",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Claire Peluchon",
                            "role": "CONTACT",
                            "phone": "+33 (0) 2 53 48 22 43",
                            "email": "claire.peluchon@chu-nantes.fr"
                        },
                        {
                            "name": "Thomas Gastinne",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "Nantes University Hospital Center - Hotel Dieu Hospital",
                    "status": "RECRUITING",
                    "city": "Nantes",
                    "zip": "44093",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Tiphaine Chiron",
                            "role": "CONTACT",
                            "phone": "+33 (0) 240 08 40 30",
                            "email": "tiphaine.chiron@chu-nantes.fr"
                        },
                        {
                            "name": "Thomas Gastinne",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "Strasbourg Europe Institut of Cancerology",
                    "status": "RECRUITING",
                    "city": "Strasbourg",
                    "zip": "23025",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Lucie-Anne Casper",
                            "role": "CONTACT",
                            "phone": "+33 (0) 368767150",
                            "email": "a.casper@icans.eu"
                        },
                        {
                            "name": "Lauriane Eberst",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.58392,
                        "lon": 7.74553
                    }
                },
                {
                    "facility": "Gustave Roussy",
                    "status": "RECRUITING",
                    "city": "Villejuif",
                    "zip": "94805",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Mariem Labiadh",
                            "role": "CONTACT",
                            "phone": "+33 (0) 142 11 61 72",
                            "email": "Mariem.LABIADH@gustaveroussy.fr"
                        },
                        {
                            "name": "Vincent Ribrag, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.7939,
                        "lon": 2.35992
                    }
                },
                {
                    "facility": "Irccs University Hospital of Bologna",
                    "status": "RECRUITING",
                    "city": "Bologna",
                    "zip": "40138",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Silvia Corazza",
                            "role": "CONTACT",
                            "phone": "39 051 214 3231",
                            "email": "silvia.corazza3@unibo.it"
                        },
                        {
                            "name": "Pier Luigi Zinzani, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.49381,
                        "lon": 11.33875
                    }
                },
                {
                    "facility": "Gruppo Humanitas - Humanitas Research Hospital - Cancer Center",
                    "status": "RECRUITING",
                    "city": "Milan",
                    "zip": "20089",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Laura Paladini",
                            "role": "CONTACT",
                            "phone": "39 02 8224 5954",
                            "email": "laura.paladini@cancercenter.humanitas.it"
                        },
                        {
                            "name": "Carmelo Carlo-Stella",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "University Polyclinic Foundation \"Agostino Gemelli\" - IRCCS",
                    "status": "RECRUITING",
                    "city": "Rome",
                    "zip": "00168",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Giulia Ferrara",
                            "role": "CONTACT",
                            "phone": "+39 (06) 30158 545",
                            "email": "giulia.ferrera@policlinicogemelli.it"
                        },
                        {
                            "name": "Domenica Lorusso",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Gangnam Severance Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Mina Jang",
                            "role": "CONTACT",
                            "phone": "8210-8737-0811",
                            "email": "mnj2023sc@yuhs.ac"
                        },
                        {
                            "name": "Jae-Hoon Kim",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Polish Mother's Memorial Hospital-Research Institute",
                    "status": "RECRUITING",
                    "city": "Lodz",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Marta Grubiak",
                            "role": "CONTACT",
                            "phone": "0048 792 206 646",
                            "email": "grubiak.marta@gmail.com"
                        },
                        {
                            "name": "Ewa Kalinka",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.75,
                        "lon": 19.46667
                    }
                },
                {
                    "facility": "Medical Center Pratia Poznan",
                    "status": "RECRUITING",
                    "city": "Skorzewo,",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Justyna Zwierzchowska",
                            "role": "CONTACT",
                            "phone": "0048 512 491 461",
                            "email": "justyna.zwierzchowska@pratia.com"
                        },
                        {
                            "name": "Marek Kotlarski, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ]
                },
                {
                    "facility": "Maria Sklodowska-Curie - National Research Institute of Oncology",
                    "status": "RECRUITING",
                    "city": "Warsaw",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Karolina Kolakowska",
                            "role": "CONTACT",
                            "phone": "0048 22 546 2248",
                            "email": "karolina.kolakowska@pib-nio.pl"
                        },
                        {
                            "name": "Jan Walewski, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "University Clinical Hospital of Salamanca",
                    "status": "RECRUITING",
                    "city": "Salamanca",
                    "state": "Castilla Y Leon",
                    "zip": "37007",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Manuel Delgado Criado",
                            "role": "CONTACT",
                            "phone": "+34 (923) 291 316",
                            "email": "mdelgadocri@saludcastillayleon.es"
                        },
                        {
                            "name": "Martin Garcia-Sancho, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.96882,
                        "lon": -5.66388
                    }
                },
                {
                    "facility": "University Hospital Complex of Santiago (CHUS)",
                    "status": "RECRUITING",
                    "city": "Santiago De Compostela",
                    "state": "Galicia",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Carolina Garcia Martinez",
                            "role": "CONTACT",
                            "phone": "+34981950512/ +3498195567",
                            "email": "cgarciamartinez.enf@gmail.com"
                        },
                        {
                            "name": "Teresa Curiel Garcia",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.88052,
                        "lon": -8.54569
                    }
                },
                {
                    "facility": "University Hospital Vall d'Hebron",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Laia Gispert (Hematology)",
                            "role": "CONTACT",
                            "phone": "+34 93 254 34 50",
                            "email": "laiagispert@vhio.net"
                        },
                        {
                            "name": "Albert Meire (Oncology)",
                            "role": "CONTACT",
                            "phone": "+34 93 274 60 00",
                            "phoneExt": "4691",
                            "email": "ameire@vhio.net"
                        },
                        {
                            "name": "Francesc Bosch Albareda",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "University Hospital of Girona Dr. Josep Trueta",
                    "status": "RECRUITING",
                    "city": "Girona",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Nuria Martin",
                            "role": "CONTACT",
                            "phone": "+34 972 75 49 53",
                            "email": "nmartin@iconcologia.net"
                        },
                        {
                            "name": "Maria Pilar Barretina Ginesta",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.98311,
                        "lon": 2.82493
                    }
                },
                {
                    "facility": "University Clinic of Navarra - Madrid",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Maria Aleman Ramos",
                            "role": "CONTACT",
                            "phone": "+34 (91) 353 1920 Ext 7539",
                            "email": "maleman@unav.es"
                        },
                        {
                            "name": "Antonio Gonzalez Martin",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "University Hospital 12 de Octubre",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Irene Pascual",
                            "role": "CONTACT",
                            "phone": "+34 913908626",
                            "email": "ipascualsr.imas12@h12o.es"
                        },
                        {
                            "name": "Luis Manso Sanchez",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "University Hospital Quiron Madrid",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Uxue Nunez",
                            "role": "CONTACT",
                            "phone": "+34 914521900 (ext. 38901)",
                            "email": "uxnunez@nextoncology.eu"
                        },
                        {
                            "name": "Valentina Boni",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "University Hospital Son Espases",
                    "status": "RECRUITING",
                    "city": "Palma De Mallorca",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Neomi Ceron Pisa",
                            "role": "CONTACT",
                            "phone": "+34 871 20 61 30",
                            "email": "noemi.ceron@ssib.es"
                        },
                        {
                            "name": "Jesus Alarcon",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.56939,
                        "lon": 2.65024
                    }
                },
                {
                    "facility": "University Clinic of Navarra - Pamplona",
                    "status": "RECRUITING",
                    "city": "Pamplona",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Mercedes Egana Gorraiz",
                            "role": "CONTACT",
                            "phone": "+34 (948) 255 400 Ext 2733",
                            "email": "megana@unav.es"
                        },
                        {
                            "name": "Ana Landa Magdalena",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.81687,
                        "lon": -1.64323
                    }
                },
                {
                    "facility": "University Hospital Virgen del Rocio (HUVR)",
                    "status": "RECRUITING",
                    "city": "Seville",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Montserrat Dominguez",
                            "role": "CONTACT",
                            "phone": "+34 (696) 635-551",
                            "email": "montse.oncologiahuvr@gmail.com"
                        },
                        {
                            "name": "Alejandro Falcon Gonzalez",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.38283,
                        "lon": -5.97317
                    }
                },
                {
                    "facility": "Valencia Oncology Institute (IVO)",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Lidia Riquelme",
                            "role": "CONTACT",
                            "phone": "+34 663224865",
                            "email": "datamanager3@fincivo.org"
                        },
                        {
                            "name": "Angel Guerrero Zotano",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Royal United Hospital",
                    "status": "RECRUITING",
                    "city": "Bath",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Samantha Curtis",
                            "role": "CONTACT",
                            "phone": "01225 824288",
                            "email": "samantha.curtis@nhs.net"
                        },
                        {
                            "name": "Rebecca Bowen",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.3751,
                        "lon": -2.36172
                    }
                },
                {
                    "facility": "University Hospitals of Leicester NHS Trust",
                    "status": "RECRUITING",
                    "city": "Leicester",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Sarah Porter",
                            "role": "CONTACT",
                            "phone": "0116 258 7598",
                            "email": "sarah.porter@uhl-tr.nhs.uk"
                        },
                        {
                            "name": "Harriet Walter, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.6386,
                        "lon": -1.13169
                    }
                },
                {
                    "facility": "The Christie NHS Foundation Trust, Department of Medical Oncology",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Amy Pearce",
                            "role": "CONTACT",
                            "phone": "0161 918 7688"
                        },
                        {
                            "name": "Andrew Clamp",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                },
                {
                    "facility": "Royal Marsden Hospital - Sutton",
                    "status": "RECRUITING",
                    "city": "Sutton",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Abiramy Neduncheliyan",
                            "role": "CONTACT",
                            "phone": "0208 661 3808",
                            "email": "Abiramy.Neduncheliyan@rmh.nhs.uk"
                        },
                        {
                            "name": "Susana Banerjee",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.35,
                        "lon": -0.2
                    }
                },
                {
                    "facility": "Musgrove Park Hospital",
                    "status": "RECRUITING",
                    "city": "Taunton",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Tamlyn Russel",
                            "role": "CONTACT",
                            "phone": "01823 342582",
                            "email": "Tamlyn.Russell@SomersetFT.nhs.uk"
                        },
                        {
                            "name": "Emma Cattell",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.01494,
                        "lon": -3.10293
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000016403",
                    "term": "Lymphoma, Large B-Cell, Diffuse"
                },
                {
                    "id": "D000016889",
                    "term": "Endometrial Neoplasms"
                },
                {
                    "id": "D000008654",
                    "term": "Mesothelioma"
                },
                {
                    "id": "D000086002",
                    "term": "Mesothelioma, Malignant"
                },
                {
                    "id": "D000011471",
                    "term": "Prostatic Neoplasms"
                },
                {
                    "id": "D000055331",
                    "term": "Adenomyoepithelioma"
                },
                {
                    "id": "D000018262",
                    "term": "Adenocarcinoma, Clear Cell"
                },
                {
                    "id": "D000016399",
                    "term": "Lymphoma, T-Cell"
                },
                {
                    "id": "D000064129",
                    "term": "Prostatic Neoplasms, Castration-Resistant"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000016393",
                    "term": "Lymphoma, B-Cell"
                },
                {
                    "id": "D000008228",
                    "term": "Lymphoma, Non-Hodgkin"
                },
                {
                    "id": "D000014594",
                    "term": "Uterine Neoplasms"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000014591",
                    "term": "Uterine Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000000236",
                    "term": "Adenoma"
                },
                {
                    "id": "D000018301",
                    "term": "Neoplasms, Mesothelial"
                },
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000010997",
                    "term": "Pleural Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000005834",
                    "term": "Genital Neoplasms, Male"
                },
                {
                    "id": "D000005832",
                    "term": "Genital Diseases, Male"
                },
                {
                    "id": "D000011469",
                    "term": "Prostatic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000018193",
                    "term": "Neoplasms, Complex and Mixed"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11222",
                    "name": "Lymphoma, Non-Hodgkin",
                    "relevance": "LOW"
                },
                {
                    "id": "M18828",
                    "name": "Lymphoma, B-Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M18831",
                    "name": "Lymphoma, Large B-Cell, Diffuse",
                    "asFound": "Diffuse Large B-Cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14335",
                    "name": "Prostatic Neoplasms",
                    "asFound": "Prostatic Neoplasms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18829",
                    "name": "Lymphoma, T-Cell",
                    "asFound": "Lymphoma, T-Cell",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11634",
                    "name": "Mesothelioma",
                    "asFound": "Mesothelioma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2537",
                    "name": "Mesothelioma, Malignant",
                    "asFound": "Mesothelioma, Malignant",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M20408",
                    "name": "Adenocarcinoma, Clear Cell",
                    "asFound": "Clear Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30215",
                    "name": "Prostatic Neoplasms, Castration-Resistant",
                    "asFound": "Prostatic Neoplasms, Castration-Resistant",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28121",
                    "name": "Adenomyoepithelioma",
                    "asFound": "Clear Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M19235",
                    "name": "Endometrial Neoplasms",
                    "asFound": "Endometrial Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M17342",
                    "name": "Uterine Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17339",
                    "name": "Uterine Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M3591",
                    "name": "Adenoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20445",
                    "name": "Neoplasms, Mesothelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M13887",
                    "name": "Pleural Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8946",
                    "name": "Genital Neoplasms, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M8944",
                    "name": "Genital Diseases, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M14333",
                    "name": "Prostatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T640",
                    "name": "B-cell Lymphoma",
                    "asFound": "B-cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1866",
                    "name": "Diffuse Large B-Cell Lymphoma",
                    "asFound": "Diffuse Large B-Cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3584",
                    "name": "Malignant Mesothelioma",
                    "asFound": "Mesothelioma, Malignant",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2125",
                    "name": "Epithelial-myoepithelial Carcinoma",
                    "asFound": "Clear Cell Carcinoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M29348",
                    "name": "Topoisomerase Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}